Moderna completes enrollment in Covid vaccine study

Moderna Inc said on Thursday it had completed the enrollment of 30,000 participants in a late-stage study testing its experimental coronavirus vaccine, with over a third of the participants from communities of color. Over 25,650 participants have so far received their second shot of the vaccine candidate, mRNA-1273, the company said.